FDA Inspection 1160694 — Charles E. Canter, MD

Charles E. Canter, MD — FEI 3020908057

The FDA completed an inspection of Charles E. Canter, MD on Dec 20, 2021 in Saint Louis, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 20, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Saint Louis, MO (United States)

Additional Details

Clinical Investigator (CI)